C. Eppolito

发表

LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model

K. Odunsi, P. Shrikant, J. Matsuzaki, 2015, Oncotarget.

Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction

Fumito Ito, K. Odunsi, S. Battaglia, 2022, Cancer Immunology and Immunotherapy.

IL-12-Programmed Long-Term CD8+ T Cell Responses Require STAT41

Qingsheng Li, K. Odunsi, P. Shrikant, 2006, The Journal of Immunology.

Require STAT 4 T Cell + IL-12-Programmed Long-Term CD 8

Qingsheng Li, K. Odunsi, P. Shrikant, 2006 .

Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction

Fumito Ito, K. Odunsi, S. Battaglia, 2022, Cancer Immunology, Immunotherapy.

Delivery Gene IL-15 and IL-21 Combined with Expressing the HIV-1 Env Glycoprotein when Immune Responses Induced by DNA Vaccine Increased Level and Longevity of Protective

L. Stamatatos, P. Shrikant, D. Kozbor, 2006 .

The acute phase protein haptoglobin regulates host immunity

K. Huntoon, P. Shrikant, F. Berger, 2008, Journal of leukocyte biology.

Doxorubicin plus tumor necrosis factor α combination treatments in EL4-lymphoma-bearing C57BL/6 mice

M. J. Ehrke, S. Verstovsek, J. M. Meer, 1998, Cancer Immunology, Immunotherapy.

Regulating functional cell fates in CD8 T cells

Qingsheng Li, Rajesh R. Rao, P. Shrikant, 2010, Immunologic research.

Antigen‐induced Erk1/2 activation regulates Ets‐1‐mediated sensitization of CD8+ T cells for IL‐12 responses

Qingsheng Li, K. Odunsi, P. Shrikant, 2010, Journal of leukocyte biology.

IL-21 Enhances and Sustains CD8+ T Cell Responses to Achieve Durable Tumor Immunity: Comparative Evaluation of IL-2, IL-15, and IL-211

Qingsheng Li, C. Clegg, P. Shrikant, 2004, The Journal of Immunology.

A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer

K. Odunsi, D. Kozbor, T. Keler, 2021, Cancer Immunology, Immunotherapy.

Immunity : Comparative Evaluation of IL-2 , Responses to Achieve Durable Tumor T Cell + IL-21 Enhances and Sustains CD 8

Qingsheng Li, C. Clegg, P. Shrikant, 2004 .

Aspergillus fumigatus extract differentially regulates antigen‐specific CD4+ and CD8+ T cell responses to promote host immunity

Qingsheng Li, P. Shrikant, B. Segal, 2006, Journal of leukocyte biology.

Selective modulation by alpha-difluoromethylornithine of T-lymphocyte and antibody-mediated cytotoxic responses to mouse tumor allografts.

M. J. Ehrke, C. Porter, E. Mihich, 1986, Cancer research.

Tumor-infiltrating NY-ESO-1–specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

Lloyd J. Old, Kunle Odunsi, Austin Miller, 2010, Proceedings of the National Academy of Sciences.

Fidelity of human ovarian cancer patient-derived xenografts in a partially humanized mouse model for preclinical testing of immunotherapies

Jianmin Wang, A. Odunsi, A. McGray, 2020, Journal for ImmunoTherapy of Cancer.

The effect of PS-K, a protein bound polysaccharide, on immune responses against allogeneic antigens.

M. J. Ehrke, E. Mihich, C. Eppolito, 1983, International journal of immunopharmacology.

Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer

M. Seshadri, K. Odunsi, S. Battaglia, 2019, Journal of Immunotherapy for Cancer.

Angiostatic activity of the antitumor cytokine interleukin-21.

W. Leonard, A. Griffioen, J. V. van Beijnum, 2008, Blood.

Characterizing Host Immune Responses by Monitoring Fluorescently Marked Cells

Qingsheng Li, P. Shrikant, C. Eppolito, 2007, Immunological investigations.

CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer

K. Odunsi, P. Shrikant, S. Battaglia, 2020, Journal for ImmunoTherapy of Cancer.

The Shiga toxin B‐subunit targets antigen in vivo to dendritic cells and elicits anti‐tumor immunity

Steffen Jung, E. Tartour, W. Fridman, 2006, European journal of immunology.

Increased Level and Longevity of Protective Immune Responses Induced by DNA Vaccine Expressing the HIV-1 Env Glycoprotein when Combined with IL-21 and IL-15 Gene Delivery1

L. Stamatatos, P. Shrikant, D. Kozbor, 2006, The Journal of Immunology.

Identification, characterization, and cloning of TIP-B1, a novel protein inhibitor of tumor necrosis factor-induced lysis.

M. J. Ehrke, A. Henn, E. Mihich, 1999, Cancer research.

Identification, characterization, and cloning of TIP-B1, a novel protein inhibitor of tumor necrosis factor-induced lysis.

M. J. Ehrke, A. Henn, E. Mihich, 1999, Cancer research.

Abstract PR12: Epigenetic reprograming promotes an immunogenic ovarian tumor microenvironment and synergizes with adoptive transfer of engineered T cells expressing NY-ESO-1 specific T cell receptors

R. Koya, J. Matsuzaki, A. Odunsi, 2018, Immunotherapy.

CXCR6 enforced retention promotes resident memory CD8 T cell- mediated immunosurveillance and control of ovarian cancer

K. Odunsi, P. Shrikant, S. Battaglia, 2021 .

CXCR6 governs the retention of tissue-resident memory T cells to promote enhanced surveillance and control of ovarian cancer

K. Odunsi, P. Shrikant, S. Battaglia, 2020 .

TNF-alpha potentiation of the lymphokine-activated killer response of murine thymus cells.

M. J. Ehrke, E. Mihich, D. Maccubbin, 1994, Lymphokine and cytokine research.

Immunological responses critical to the therapeutic effects of adriamycin plus interleukin 2 in C57BL/6 mice bearing syngeneic EL4 lymphoma.

M. J. Ehrke, G. Zaleskis, E. Mihich, 1993, Oncology research.

negatively regulated by LAG-3 and PD-1 in human ovarian cancer

K. Odunsi, L. Old, Austin Miller, 2010 .

Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction

K. Odunsi, S. Battaglia, R. Koya, 2022, Cancer Immunology, Immunotherapy.